Vehicle floor assembly with insert
    6.
    发明授权
    Vehicle floor assembly with insert 失效
    车载地板总成与插入

    公开(公告)号:US08641128B2

    公开(公告)日:2014-02-04

    申请号:US12537294

    申请日:2009-08-07

    申请人: David Edwards

    发明人: David Edwards

    IPC分类号: B62D27/02 E04C5/16

    CPC分类号: B62D25/2054

    摘要: An insert that can be used support a vehicle floor if a cross member fails either mechanically or through corrosion. The insert may also be used to protect a fastener used in a vehicle floor assembly.

    摘要翻译: 如果交叉构件机械地或通过腐蚀失效,则可以使用的插入件支撑车辆底板。 插入件也可用于保护用于车辆地板组件中的紧固件。

    Method and device for decreasing contamination

    公开(公告)号:US20080038207A1

    公开(公告)日:2008-02-14

    申请号:US11827031

    申请日:2007-07-10

    IPC分类号: A61K31/70 A01N37/18

    CPC分类号: A61B5/097 G01N33/497

    摘要: Methods and devices to determine rate of particle production and the size range for the particles produced for an individual are described herein. The device (10) contains a mouthpiece (12), a filter (14), a low resistance one-way valve (16), a particle counter (20) and a computer (30). Optionally, the device also contains a gas flow meter (22). The data obtained using the device can be used to determine if a formulation for reducing particle exhalation should be administered to an individual. This device is particularly useful prior to and/or following entry in a cleanroom to ensure that the cleanroom standards are maintained. The device can also be used to identify animals and humans who have an enhanced propensity to exhale aerosols (referred to herein as “over producers”, “super-producers”, or “superspreaders”). Formulations to reduce particle production are also described herein. The formulation is administered in an amount sufficient to alter biophysical properties in the mucosal linings of the body. When applied to mucosal lining fluids, the formulation alters the physical properties such as the gel characteristics at the air/liquid interface, surface elasticity, surface viscosity, surface tension and bulk viscoelasticity of the mucosal lining. The formulation is administered in an effective amount to minimize ambient contamination due to particle formation during breathing, coughing, sneezing, or talking, which is particularly important in cleanroom applications. In one embodiment, the formulation for administration is a non-surfactant solution. In one embodiment, the formulations are conductive formulations containing conductive agents, such as salts, ionic surfactants, or other substances that are in an ionized state or easily ionized in an aqueous or organic solvent environment. Preferably the formulation is administered in the form of an aerosol.